代謝體學：技術與全球市場

Metabolomics: Technologies and Global Markets

出版日期: 2024年06月20日 | 出版商:

BCC Research | 英文 99 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球代謝體學市場規模預計將從 2024 年的 164 億美元增至 2029 年底的302 億美元，預測期內複合年成長率為 13.1%。

預計到 2029年終，分離技術產業將從 2024 年的 83 億美元增至 154 億美元，複合年成長率為 13.1%。此外，檢測技術產業預計將從 2024 年的 80 億美元成長到 2029年終的148 億美元，複合年成長率為 13.0%。

本報告調查了全球代謝體學市場，並提供了市場概況、市場影響因素和市場機會分析、新興技術和技術發展趨勢、市場規模趨勢和預測、各個細分市場和地區的詳細分析以及競爭資訊。現狀、主要企業簡介等

細分細分
代謝體學市場：依產品
全球市場分析與預測
分離技術
檢測技術
代謝體學市場：依適應症分類
全球市場分析與預測
癌症
心血管疾病
神經系統疾病
先天性代謝缺陷
其他
代謝體學市場：依應用分類
全球市場分析與預測
生物標記發現
藥物發現
毒性試驗
營養基因體學
功能基因體學
其他
代謝體學市場：按地區
世界
北美洲
歐洲
亞太地區
其他地區

第6章競爭訊息

企業市場占有率分析
戰略分析
M&A
創業投資資金籌措

第7章附錄

調查方法
簡稱
來源
公司簡介
AGILENT TECHNOLOGIES INC.
BIO-RAD LABORATORIES INC.
BRUKER
DANAHER CORP.
MERCK KGAA
SHIMADZU CORP.
THERMO FISHER SCIENTIFIC INC.
WATERS CORP.

簡介目錄圖表

Product Code: BIO055E

The global market for metabolomics technologies is expected to grow from $16.4 billion in 2024 and is projected to reach $30.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2024 to 2029.

The global market for separation techniques for metabolomics technologies is expected to grow from $8.3 billion in 2024 and is projected to reach $15.4 billion by the end of 2029, at a CAGR of 13.1% during the forecast period of 2024 to 2029.

The global market for detection techniques for metabolomics technologies is expected to grow from $8.0 billion in 2024 and is projected to reach $14.8 billion by the end of 2029, at a CAGR of 13.0% during the forecast period of 2024 to 2029.

Report Scope

This report is a comprehensive study of the global metabolomics technologies market. Current and historical market revenues are estimated based on product, indication, application and region.

Report Includes

32 data tables and 39 additional tables
An overview of the global market for metabolomics, the study of small molecules, known as metabolites, in cells, biofluids, tissues and organisms
Analysis of global market trends, featuring revenue data for 2021-2023, estimates for 2024, forecasts for 2029 and projected CAGRs through 2029
Evaluation of the current market's size and revenue growth prospects, along with a market share analysis by product, indication, application, and region
Analysis of the market drivers, restraints and opportunities, and identification of the companies best positioned to meet the demand for metabolics
A look at ESG trends
Information on developments in R&D, clinical trials, emerging technologies, and economic trends
Analysis of key companies' market shares, proprietary technologies, patents, and alliances
Profiles of the leading companies, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker, Danaher Corp., and Merck KGaA

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Overview
Overview of Metabolomics
Separation Techniques
Detection Techniques
Metabolites and Their Applications
R&D and Regulatory Approval
Supply Chain Analysis

Chapter 3 Market Dynamics

Market Dynamics Snapshot
Market Drivers
Technological Advancements
Increasing Healthcare Expenditure
Expanding Applications Across Industries
Market Restraints
High Cost of Instruments and Services
Complexity of Data Analysis
Standardization and Quality Control Challenges
Limited Biomarker Validation and Clinical Utility
Market Opportunities
Precision Medicine and Personalized Healthcare
Drug Discovery and Development
Biomarker Discovery and Validation
Nutritional Profiling and Functional Foods
Environmental Monitoring and Toxicology
Market Challenges
Data Complexity and Interpretation
Standardization and Quality Assurance
Biomarker Validation and Clinical Translation
Technological Limitations and Costs
Regulatory and Ethical Considerations

Chapter 4 Emerging Technologies and Developments

Introduction
Clinical Trial Analysis
By Study Type
By Status
By Gender
By Interventions
Granted Patents
Introduction
Patent Analysis

Chapter 5 Market Segmentation Analysis

Segmentation Breakdown
Metabolomics Market, by Product
Global Market Analysis and Forecast
Separation Techniques
Detection Techniques
Metabolomics Market, by Indication
Global Market Analysis and Forecast
Cancer
Cardiovascular Disorders
Neurological Disorders
Inborn Errors of Metabolism
Other Diseases Indication
Metabolomics Market, by Application
Global Market Analysis and Forecast
Biomarker Discovery
Drug Discovery
Toxicology Testing
Nutrigenomics
Functional Genomics
Others
Geographic Breakdown
Metabolomics Market, by Region
Global
North America
Europe
Asia-Pacific
Rest of the World

Chapter 6 Competitive Intelligence

Company Share Analysis
Strategic Analysis
Mergers and Acquisitions
Venture Capital Funding

Chapter 7 Appendix

Methodology
Sources
Acronyms
Definitions/Taxonomy
Company Profiles
AGILENT TECHNOLOGIES INC.
BIO-RAD LABORATORIES INC.
BRUKER
DANAHER CORP.
MERCK KGAA
SHIMADZU CORP.
THERMO FISHER SCIENTIFIC INC.
WATERS CORP.

簡介目錄圖表

List of Tables

Summary Table : Global Market for Metabolomics Technologies, by Product, Through 2029
Table 1 : Publications Referencing Metabolomics, 2021-2023
Table 2 : Mass Spectrometry Products from Different Global Players
Table 3 : Prices of Mass Spectrometry Products from Different Global Players
Table 4 : Mass Spectrometry Steps to Metabolite Identification
Table 5 : Various Metabolites and Their Functions and Applications
Table 6 : Metabolomics Supply Chain
Table 7 : Metabolomics Supply Chain Examples
Table 8 : List of Bioinformatics Tools Used in Metabolomics
Table 9 : List of Biomarkers Used in the Metabolomics and Applications
Table 10 : Global Regulatory and Ethical Considerations for Metabolomics-Based Products
Table 11 : Metabolomics Emerging Technologies
Table 12 : Selected Clinical Trials Data for Metabolomics, 2021-2024
Table 13 : Selected Granted Patents of Metabolomics, 2022 and 2023
Table 14 : Global Market for Metabolomics Technologies, by Product, Through 2029
Table 15 : Global Market for Separation Techniques in Metabolomics Technologies, by Region, Through 2029
Table 16 : Global Market for Detection Techniques in Metabolomics Technologies, by Region, Through 2029
Table 17 : Global Market for Metabolomics Technologies, by Disease Indication, Through 2029
Table 18 : Global Market for Metabolomics Technologies for Cancer Indication, by Region, Through 2029
Table 19 : Global Market for Metabolomics Technologies for Cardiovascular Disorders, by Region, Through 2029
Table 20 : Global Market for Metabolomics Technologies for Neurological Disorders, by Region, Through 2029
Table 21 : Global Market for Metabolomics Technology for Inborn Errors of Metabolism, by Region, Through 2029
Table 22 : Global Market for Metabolomics Technologies for Other Diseases Indication, by Region, Through 2029
Table 23 : Global Market for Metabolomics Technologies, by Application, Through 2029
Table 24 : Global Market for Metabolomics Technologies in Biomarker Discovery, by Region, Through 2029
Table 25 : Global Market for Metabolomics Technologies in Drug Discovery, by Region, Through 2029
Table 26 : Global Market for Metabolomics Technologies in Toxicology Testing, by Region, Through 2029
Table 27 : Global Market for Metabolomics Technologies in Nutrigenomics, by Region, Through 2029
Table 28 : Global Market for Metabolomics Technologies in Functional Genomics, by Region, Through 2029
Table 29 : Global Market for Metabolomics Technologies in Other Applications, by Region, Through 2029
Table 30 : Global Market for Metabolomics Technologies, by Region, Through 2029
Table 31 : North American Market for Metabolomics Technologies, by Country, Through 2029
Table 32 : European Market for Metabolomics Technologies, by Country, Through 2029
Table 33 : Asia-Pacific Market for Metabolomics Technologies, by Country, Through 2029
Table 34 : Rest of the World Market for Metabolomics Technologies, Through 2029
Table 35 : Merger and Acquisitions in the Global Market for Metabolomics Technologies, 2023
Table 36 : Funded Projects for Metabolomics Technologies, 2021-2024
Table 37 : Report Sources
Table 38 : Major Acronyms Used in This Report
Table 39 : Agilent Technologies Inc.: Company Snapshot
Table 40 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 41 : Agilent Technologies Inc.: Product Portfolio
Table 42 : Agilent Technologies Inc.: News/Key Developments, 2023 and 2024
Table 43 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 44 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 45 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 46 : Bio-Rad Laboratories Inc.: News/Key Developments, 2023 and 2024
Table 47 : Bruker: Company Snapshot
Table 48 : Bruker: Financial Performance, FY 2022 and 2023
Table 49 : Bruker: Product Portfolio
Table 50 : Bruker: News/Key Developments, 2023
Table 51 : Danaher Corp.: Company Snapshot
Table 52 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 53 : Danaher Corp.: Product Portfolio
Table 54 : Danaher Corp.: News/Key Developments, 2023 and 2024
Table 55 : Merck KGaA: Company Snapshot
Table 56 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 57 : Merck KGaA: Product Portfolio
Table 58 : Merck KGaA: News/Key Developments, 2023
Table 59 : Shimadzu Corp.: Company Snapshot
Table 60 : Shimadzu Corp.: Financial Performance, FY 2021 and 2022
Table 61 : Shimadzu Corp.: Product Portfolio
Table 62 : Shimadzu Corp.: News/Key Developments, 2023
Table 63 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 64 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 65 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 66 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023
Table 67 : Waters Corp.: Company Snapshot
Table 68 : Waters Corp.: Financial Performance, FY 2022 and 2023
Table 69 : Waters Corp.: Product Portfolio
Table 70 : Waters Corp.: News/Key Developments, 2023

List of Figures

Summary Figure : Global Market for Metabolomics Technologies, by Product, 2024-2029
Figure 1 : Publications Referencing Metabolomics, 2021-2023
Figure 2 : Different Metabolomics Techniques
Figure 3 : Schematic Diagram of Mass Spectrometry
Figure 4 : Market Dynamics of Global Metabolomics Technologies
Figure 5 : Global Healthcare Expenditure, 2021-2023
Figure 6 : Global Shares of Metabolomics Clinical Trials, by Study, 2024
Figure 7 : Global Shares of Metabolomics Clinical Trials, by Status, 2024
Figure 8 : Global Shares of Metabolomics Clinical Trials, by Gender, 2024
Figure 9 : Global Metabolomics Clinical Trials, by Interventions, 2024
Figure 10 : Selected Granted Patents Involving Metabolomics, by Applicant, 2022 and 2023
Figure 11 : Global Market Shares of Metabolomics Technologies, by Product, 2023
Figure 12 : Global Market Shares of Metabolomics Technologies, by Disease Indication, 2023
Figure 13 : Global Market Shares of Metabolomics Technologies, by Application, 2023
Figure 14 : Global Market Shares of Metabolomics Technologies, by Region, 2023
Figure 15 : North American Market Shares of Metabolomics Technologies, by Country, 2023
Figure 16 : European Market Shares of Metabolomics Technologies, by Country, 2023
Figure 17 : Asia-Pacific Market Shares of Metabolomics Technologies, by Country, 2023
Figure 18 : Global Market Shares of Metabolomics Technologies, by Company, 2023
Figure 19 : Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 20 : Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 21 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 22 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 23 : Bruker: Revenue Shares, by Business Unit, FY 2023
Figure 24 : Bruker: Revenue Shares, by Country/Region, FY 2023
Figure 25 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 26 : Danaher Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 27 : Merck KGaA: Revenue Shares, by Business Unit, FY 2023
Figure 28 : Merck KGaA: Revenue Shares, by Country/Region, FY 2023
Figure 29 : Shimadzu Corp.: Revenue Shares, by Business Unit, FY 2022
Figure 30 : Shimadzu Corp.: Revenue Shares, by Country/Region, FY 2022
Figure 31 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 32 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 33 : Waters Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 34 : Waters Corp.: Revenue Shares, by Country/Region, FY 2023